Form 4: ResMed Director Peter C. Farrell Sells 2,000 Shares
SEC Form 4 Filing
Director Peter C. Farrell sold 2,000 shares of ResMed Inc. common stock at a price of $248.74 per share on November 6, 2024.
Summary
- Peter C. Farrell, a director at ResMed Inc., sold 2,000 shares of the company's common stock on November 6, 2024.
- The sale was executed at a price of $248.74 per share.
- Following the transaction, Farrell directly owns 83,204 shares of ResMed common stock.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 28, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale by a director under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment towards the company's prospects.
Industry Context
Sales by company directors are a normal part of corporate governance. It is important to consider the context of the sale, such as the use of a 10b5-1 plan, which allows insiders to sell shares at predetermined times to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| May 28, 2024 | Date of adoption of Rule 10b5-1 trading plan |
| November 06, 2024 | Date of stock sale transaction |
| November 07, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.